Prognostic Factors and Survival Outcome of Whole Brain Radiotherapy in Metastatic Brain Cancer- A Single Regional Cancer Centre Experience in North India.

Loeffler JS, Patchell RA, Sawaya R. Treatment of metastatic cancer. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 5th edn. Philadelphia: Lippincott-Raven Publication 1997: p. 2523.

Lin NU, Winer EP. Brain metastases: the HER2 paradigm. Clin Cancer Res 2007;13(6):1648-55.             

Tham YL, Sexton K, Kramer R, et al. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 2006;107(4):696-704.                 

Arrieta O, Villarreal-Garza C, Zamora J, et al. Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation. Radiat Oncol 2011;6:166.           

Markesbery WR, Brooks WH, Gupta GD, et al. Treatment for patients with cerebral metastases. Arch Neurol 1978;35(11):754-6.       

Posner JB. Management of central nervous system metastasis. Semin Oncol 1977;4(1):81-91.    

Tsao MN, Lloyd N, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 2012;(4):CD003869.                  

Katz HR. The relative effectiveness of radiation therapy, corticosteroids and surgery in the management of melanoma metastatic to the central nervous system. International Journal of Radiation Oncology, Biology, Physics 1981;7(7):897-906.      

Harwood AR, Simson WJ. Radiation therapy of cerebral metastases: a randomized prospective clinical trial. Int J Radiat Oncol Biol Phys 1977;2(11-12):1091-4.    

Gelber RD, Larson M, Borgelt BB, et al. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 1981;48(8):1749-53.             

Oneschuk D, Bruera E. Palliative management of brain metastases. Support Care Cancer 1998;6(4):365-72.              

Lentzsch S, Reichardt P, Weber F, et al. Brain metastases in breast cancer: prognostic factors and management. Eur J Cancer 1999;35(4):580-5.            

Lagerwaard FJ, Levendag PC, Nowak PJ, et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999;43(4):795-803. X

Sundstrom JT, Minn H, Lertola KK, et al. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 1998;30(3):296-9.

Schouten LJ, Rutten J, Huveneers HA, et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney and lung and melanoma. Cancer 2002;94(10):2698-705.                

Liu MT, Hsieh CY, Wang AY, et al. Prognostic factors affecting the outcome of brain metastasis from breast cancer. Support Care Cancer 2006;14(9):936-42.

Khuntia D, Brown P, Li J, et al. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 2006;24(8):1295-304.     

Chatani M, Matayoshi Y, Masaki N, et al. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to level of lactate dehydrogenase. Strahlenther Onkologie 1994;170(3):155-61.                    

Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. International Journal of Radiation Oncology, Biology, Physics 1980;6(1):1-9.             

Sneed PK, Larson DA, Wara WM. Radiotherapy for cerebral metastases. Neurosurgery Clinics of North America 1996;7(3):505-16.        

Sperduto PW, Kased N, Roberge D, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012;30(4):419-25.            

Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. The Oncologist 2007;12(7):884-98.            

Kim HJ, Hong S, Kim S, et al. treatment outcome of brain metastasis after the cranial radiotherapy followed by fractionated stereotactic radiotherapy and its prognostic factors. Cancer Research and Treatment 2002;34(4):284-8.